Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

74.30USD
4:01pm EDT
Change (% chg)

$-0.92 (-1.22%)
Prev Close
$75.22
Open
$74.53
Day's High
$74.62
Day's Low
$73.95
Volume
664,269
Avg. Vol
813,011
52-wk High
$75.61
52-wk Low
$58.22

Chart for

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 0.84
Market Cap(Mil.): $40,453.85
Shares Outstanding(Mil.): 537.81
Dividend: 0.19
Yield (%): 1.01

Financials

  BAX.N Industry Sector
P/E (TTM): 29.02 40.41 34.18
EPS (TTM): 2.59 -- --
ROI: 10.37 14.36 13.17
ROE: 16.02 17.59 15.15

BRIEF-Baxter Expects Sales To Grow ~5 Pct On Compounded Annual Basis At Constant Currency Rates From 2018 To 2023

* BAXTER HIGHLIGHTS BUSINESS STRATEGIES AND INNOVATION AT 2018 INVESTOR CONFERENCE

May 21 2018

BRIEF-Baxter Announces U.S. FDA Clearance Of New Spectrum IQ Infusion System

* BAXTER ANNOUNCES U.S. FDA CLEARANCE OF NEW SPECTRUM IQ INFUSION SYSTEM Source text for Eikon: Further company coverage:

May 14 2018

BRIEF-Baxter Declares Dividend And Announces Quarterly Dividend Increase

* BAXTER DECLARES DIVIDEND AND ANNOUNCES QUARTERLY DIVIDEND INCREASE

May 08 2018

BRIEF-Baxter International Posts Q1 GAAP Earnings Per Share $0.71 From Continuing Operations

* BAXTER REPORTS FIRST-QUARTER 2018 RESULTS AND INCREASES FINANCIAL OUTLOOK FOR FULL-YEAR 2018

Apr 26 2018

BRIEF-Ameren CEO Warner Baxter's 2017 Total Compensation Was $8.1 Mln‍​

* AMEREN CORP CEO WARNER L. BAXTER'S 2017 TOTAL COMPENSATION WAS $8.1 MILLION VERSUS $6.6 MILLION IN 2016 – SEC FILING‍​ Source text - http://bit.ly/2FOolXi Further company coverage:

Mar 19 2018

BRIEF-Baxter Announces Dividend, Additional Share Repurchase

* BAXTER DECLARES QUARTERLY DIVIDEND AND ANNOUNCES EXPANDED SHARE REPURCHASE AUTHORIZATION

Feb 20 2018

Baxter forecasts upbeat 2018; expects more buybacks, deals

Baxter International Inc on Thursday forecast 2018 earnings largely ahead of analysts' estimates and said it would continue to be active on the acquisition front and repurchase more shares through the year.

Feb 01 2018

UPDATE 3-Baxter forecasts upbeat 2018; expects more buybacks, deals

* Shares down 2.7 pct (Adds conference call and analyst comments; updates shares)

Feb 01 2018

BRIEF-Baxter Reports Q4 Adjusted EPS Of $0.64​

* Q4 EARNINGS PER SHARE VIEW $0.59 -- THOMSON REUTERS I/B/E/S

Feb 01 2018

Baxter International reports quarterly loss due to tax charge

Feb 1 Baxter International Inc reported quarterly loss versus year-ago profit as the hospital products maker took a charge of $354 million due to changes in the U.S. tax law.

Feb 01 2018

Earnings vs. Estimates